Get notified of page updates

Testing an Immunotherapy, Pembrolizumab, in Patients With Advanced Solid Tumors

Treatment study for people with advanced cancers

Clinicaltrials.gov identifier:
NCT02628067

Phase 2

Study Contact Information:

 

 

PRINTER FRIENDLY PAGE
Overview
Who Can Join
Details
Contact
Glossary on
off

This study is no longer enrolling.

This Study is Open To:

This study is no longer enrolling.

This Study is NOT Open To:

This study is no longer enrolling.

This study is no longer enrolling.

Study Contact Information:

 

 

Treatment study for people with advanced cancers

Clinicaltrials.gov identifier:
NCT02628067

Phase 2

Study Contact Information:

 

 

PRINTER FRIENDLY PAGE